Flowable Hemostats Market Overview:
Flowable Hemostats Market is valued at around USD 1124 million in 2022 and is expected to reach USD 1654.25 million by 2030, registering a CAGR of 7.1% over the forecast period.
Flowable hemostats are characterized by their liquid consistency and typically consist of a porcine or bovine gelatin matrix. They may also include topical thrombin. These hemostats are particularly useful in situations where application is required on hard-to-reach surfaces or in moist environments. While suitable for various surgical procedures, it's important to note that they are not intended for ophthalmic use.
The increased occurrence of bleeding diseases has made it possible to design, produce, and test flowable hemostats. Prolonged bleeding problems can arise from operational bleeding in hospitals. Several hemostat products, including collagens based on gelatin, fibrin sealants, and active thrombin preparations, are used to combat this by lowering the body's extended blood flow. Prolonged bleeding can raise the risk of infections, increase mortality, and cause unstable hemodynamics if it is not stopped.
To know more about this report @ https://wemarketresearch.com/sample-request/flowable-hemostats-market/777
Top Impacting Factors:
Worldwide pre-hospital bleeding cases are on the rise, which has increased demand for hemostatic matrix in devices based on thrombin and gelatin.
Hemostats with the ability to provide efficient hemostasis in splenic mass removal surgical cases are in high demand because they can lessen the complications that follow surgery.
There is a growing need for alternate strategies to manage bleeding before and after surgery due to an increase in trauma events worldwide and a rise in catastrophic accidents. Consequently, the market for flowable hemostats is expanding.
The demand for flowable hemostats as an efficient blood regulating agent in vascular sites is being driven by the underlying need for the creation and development of alternative mechanisms against the usage of surgical needles.
A growing need exists for the central government to provide assistance to soldiers in the event of battle emergencies, such as blood control, post-battle trauma, and cardiovascular effects, in the defense-heavy nations of China, India, and the United States. Thus, the market for flowable hemostats is expanding as a result.
Market Trends:
Because of the rise in bleeding disorders, the rise in accidents and post-traumatic injuries throughout the region, and the need for sophisticated mechanisms to replace conventional surgical needles and related equipment, North America is expected to benefit significantly.
Leading company in the healthcare manufacturing sector Baxter International introduced FLOSEAL Hemostatic Matrix as a viable flowable hemostatic substitute for conventional microporous polysaccharide powder materials.
The D-Stat flowable hemostat, manufactured by Teleflex Ltd. with clinical backing, was introduced to lower the risk of hemotoma formation in implants that produce pulses.
Within the expanding sector, there are mergers and acquisitions. In 2019, Baxtor International purchased two flowable hemostat medications from Mallinckrodt, RECOTHROM and PREVELEAK, which are both utilized for cardiovascular.
Enquire for customization in Report @ https://wemarketresearch.com/customization/flowable-hemostats-market/777
Market Segments:
On the basis of material, the Flowable Hemostats Market is bifurcated into:
- Bovine gelatin
- Porcine gelatin
- Others
On the basis of products, the market is segmented into:
- Active hemostats
- Passive hemostats
- Combination hemostats
- Others
On the basis of application, the market is segmented into:
- General surgery
- Cardiac surgery
- Orthopaedic surgery
- Neuro and spine surgery
- Others
On the basis of end-user, the market is segmented into:
- Hospitals and clinics
- Ambulatory surgery centres
- Others
Market Regional Analysis:
North America led the global market for flowable hemostats and is expected to maintain steady growth with a Compound Annual Growth Rate (CAGR) of 6.9% from 2022 to 2032. Similarly, the Asia-Pacific region is projected to witness steady growth in the flowable hemostats market, with a CAGR of 6.7% between 2022 and 2032.
Major Key Players include in this Report are:
- Johnson & Johnson
- Teleflex Incorporated
- Axiom Bio solutions
- Baxter International
- CR Bard, Inc.
- Braun Melsungen AG
- Marine Polymer Technologies
- Medico LLC
- Ethicon, Inc.
- and others.
Get a Purchase of This Report @ https://wemarketresearch.com/purchase/flowable-hemostats-market/777?license=single
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
The report "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.
In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market.On the other hand, high cost of hemostats and dearth of skilled professionals are expected to hinder the growth of this market.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9571619The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018.
Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats.
Of all these product segments, the thrombin-based hemostats segment is expected to account for the largest share of the global hemostats market in 2018.In 2018, the orthopedic surgery segment is expected to dominate the hemostats market On the basis of application, the hemostats market is segmented neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries.
The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018.In 2018, North America to command for the largest market share On the basis of region, the hemostats market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
In 2018, North America is expected to account for the largest share of the global hemostats market.
